Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Butler

Showing results (111-120 of 1,477) with videos related to

Pageof 148
Sort By:
Plos One|January 5, 2012
Bifunctional anti-huntingtin proteasome-directed intrabodies mediate efficient degradation of mutant huntingtin exon 1 protein fragmentsDavid C Butler, Anne Messer
Anaesthesia and Intensive Care|August 10, 2011
Ventilation failure as a result of internal battery leakage in an Ulco Ev500 ventilatorC Butler, G J Gianotti
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 13, 2014
Better tests also in primary careCarl Llor, Christopher C Butler
Current Drug Targets. Inflammation and Allergy|April 28, 2005
Inflammatory mediators as potential therapeutic targets in the spineSally Roberts, Robin C Butler
JAMA Internal Medicine|March 7, 2013
Glucagonlike Peptide 1-based drugs and pancreatitis: clarity at last, but what about pancreatic cancer?Belinda Gier, Peter C Butler
The Journal of Dermatological Treatment|October 2, 2018
Atopic dermatitis spectrum disorder: new conceptualization for the coming new therapeutic eraDaniel C Butler, John Koo
Annals of the New York Academy of Sciences|January 1, 1979
Leukemia virus-induced immunosuppression: reversal by subcellular factorsR C Butler, H Friedman
The Western Journal of Medicine|June 1, 1986
Physical medicine and rehabilitation: powered mobility for very young disabled childrenG A Okamoto, C Butler
Cell Metabolism|August 8, 2014
Insulin-degrading enzyme inhibition, a novel therapy for type 2 diabetes?Safia Costes, Peter C Butler
Environmental Science & Technology|May 4, 2016
Iron-Sulfide-Associated Products Formed during Reductive Dechlorination of Carbon TetrachlorideYing Lan, Elizabeth C Butler
Pageof 148

Showing results (111-120 of 1,477) with videos related to

Sort By:
Pageof 148
Plos One|January 5, 2012
Bifunctional anti-huntingtin proteasome-directed intrabodies mediate efficient degradation of mutant huntingtin exon 1 protein fragmentsDavid C Butler, Anne Messer
Anaesthesia and Intensive Care|August 10, 2011
Ventilation failure as a result of internal battery leakage in an Ulco Ev500 ventilatorC Butler, G J Gianotti
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 13, 2014
Better tests also in primary careCarl Llor, Christopher C Butler
Current Drug Targets. Inflammation and Allergy|April 28, 2005
Inflammatory mediators as potential therapeutic targets in the spineSally Roberts, Robin C Butler
JAMA Internal Medicine|March 7, 2013
Glucagonlike Peptide 1-based drugs and pancreatitis: clarity at last, but what about pancreatic cancer?Belinda Gier, Peter C Butler
The Journal of Dermatological Treatment|October 2, 2018
Atopic dermatitis spectrum disorder: new conceptualization for the coming new therapeutic eraDaniel C Butler, John Koo
Annals of the New York Academy of Sciences|January 1, 1979
Leukemia virus-induced immunosuppression: reversal by subcellular factorsR C Butler, H Friedman
The Western Journal of Medicine|June 1, 1986
Physical medicine and rehabilitation: powered mobility for very young disabled childrenG A Okamoto, C Butler
Cell Metabolism|August 8, 2014
Insulin-degrading enzyme inhibition, a novel therapy for type 2 diabetes?Safia Costes, Peter C Butler
Environmental Science & Technology|May 4, 2016
Iron-Sulfide-Associated Products Formed during Reductive Dechlorination of Carbon TetrachlorideYing Lan, Elizabeth C Butler
Pageof 148